For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions, including neurocognitive and ...
Hearing impairment is a risk factor for incident Parkinson disease (PD), according to a study published online in the February issue of Parkinsonism and Related Disorders. Megan Rose Readman, Ph.D., ...